Share
A recent event in Adelaide brought together leading ophthalmologists to explore the benefits of adopting an interventional approach to managing glaucoma.
Moderated by Brisbane-based ophthalmologist Dr. Judy Ku, the discussion featured insights from Associate Professor Shamira Perera (Singapore), Dr. Colin Clement, and Associate Professor Mitchell Lawlor (both from Sydney).
Associate Professor Perera emphasized the need to move away from the traditional "wait and see" method, advocating instead for earlier interventions to achieve better outcomes for patients. He highlighted compelling evidence that the addition of a third anti-glaucoma medication only achieves a 20% reduction in intraocular pressure (IOP) in approximately one-third of cases. Alarmingly, in 21% of cases, this strategy can actually lead to an increase in IOP.
The event also shed light on the challenges posed by the side effects of topical medications, which can significantly diminish patients' quality of life. This reinforces the importance of exploring alternative strategies that prioritize the well-being of individuals living with glaucoma.
The interventional approach, as presented by the panel, offers a promising pathway to enhance the effectiveness of glaucoma treatment while addressing the limitations of current pharmacological therapies. By focusing on proactive management, clinicians can improve long-term outcomes and quality of life for those affected by this chronic condition.
This article has been republished courtesy of Mivision
Some of our team at Glaucoma Australia were able to attend Ranzco's annual conference in Adeliade in November!
Glaucoma Australia recently hosted a congenital glaucoma brunch at the Currumbin Wildlife Sanctuary Gold Coast and what a memorable day it was!
Australia could face a staggering $4.3 billion economic burden from glaucoma by 2025 unless the Federal Government acts now to improve patient compliance, warns Glaucoma Australia.